How to convert Vitamin K1 (phylloquinone) ampule to oral tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Vitamin K1 Ampule to Oral Tablet

Oral administration of injectable vitamin K1 (phytonadione) is safe, effective, and can be used directly without reformulation—simply administer the contents of the ampule orally at the same dose. 1

Direct Conversion Approach

The injectable formulation can be administered orally by having the patient swallow the contents of the ampule directly. This approach is supported by multiple guidelines and research demonstrating that oral administration of injectable vitamin K1 is both effective and safe. 2

Key Conversion Points:

  • Dose equivalency is 1:1—if the patient is receiving 1 ampule (typically containing 1-10 mg) intravenously or intramuscularly once daily, the same dose can be given orally using the injectable preparation. 1

  • Oral bioavailability is predictable and effective, with the American College of Cardiology confirming that oral vitamin K1 administration produces reliable INR reduction within 24 hours. 1

  • Injectable vitamin K1 administered orally can be given as an undiluted solution directly from the ampule, or mixed with a small amount of juice or water if palatability is a concern. 2

Clinical Context Considerations

The appropriate oral dose depends on the clinical indication:

  • For INR 4-10 without bleeding: 1-2.5 mg oral vitamin K1 once daily is sufficient, which would be one 1-2 mg ampule given orally. 1, 3

  • For INR >10 without bleeding: 3-5 mg oral vitamin K1 is recommended, requiring a 5 mg ampule or multiple smaller ampules given orally. 1, 4

  • For nutritional supplementation in malabsorption or cystic fibrosis: 1-10 mg daily depending on age and severity, with the injectable formulation administered orally at the prescribed dose. 1

Important Caveats

  • Oral administration is NOT appropriate for emergency reversal—if rapid reversal is needed for active bleeding or emergency surgery, intravenous administration with prothrombin complex concentrate is required. 1, 3

  • The subcutaneous route should be avoided entirely, as absorption is unpredictable and sometimes delayed compared to oral administration. 1

  • Avoid high doses (≥10 mg) unless absolutely necessary, as they can cause warfarin resistance lasting up to one week and create a prothrombotic state. 1, 4

Practical Administration

  • The patient can drink the contents of the ampule directly, or it can be mixed with a small amount of liquid for easier administration. 2

  • Oral vitamin K1 takes 24 hours to substantially lower INR, so plan accordingly and do not expect immediate effects. 1

  • If transitioning from daily IV/IM ampules to oral tablets, vitamin K1 5 mg tablets can be substituted at the same daily dose once available, though injectable formulation given orally remains a cost-effective alternative. 2

  • Monitor INR 24-48 hours after the first oral dose to confirm appropriate response, especially in patients previously on parenteral therapy. 3

Cost and Availability Considerations

  • Injectable vitamin K1 administered orally provides a cost-effective alternative when oral tablets are unavailable or prohibitively expensive, as tablet costs have tripled in recent years. 2

  • The injectable formulation has proven stability and efficacy when used orally, making it a practical solution for both inpatient and outpatient settings. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Elevated INR on Warfarin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vitamin K Administration for INR Reduction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.